Latest Breaking News On - First line treatment - Page 1 : comparemela.com

Data of InnoCare's Robust Pipelines Presented at the European Hematology Association (EHA) 2024 Hybrid Congress

Data of InnoCare s robust pipelines were presented at the European Hematology Association 2024 Hybrid Congress. 1. Subcutaneous ICP-B02 , a Novel Bispecific CD20/CD3 Antibody Showed Promising.

Hong-kong
United-states
Guangzhou
Guangdong
China
Beijing
Shanghai
Nanjing
Jiangsu
Chinese
European-hematology-association

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

More than 20 abstracts will be presented from clinical trials and real-world evidence using clonoSEQ for MRD assessment across multiple types of blood cancersSEATTLE, May 31, 2024 Adaptive.

Spain
Madrid
Chicago
Illinois
United-states
University-of-chicago
American
Ciltacabtagene-autoleucel
Susan-bobulsky
Lisocabtagene-maraleucel
Obecabtagene-autoleucel
Brexucabtagene-autoleucel-brexu

Adaptive Biotechnologies Announces Data Supporting the

Adaptive Biotechnologies Announces Data Supporting the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Madrid
Spain
University-of-chicago
Illinois
United-states
Chicago
American
Idecabtagene-vicleucel-ide
Erica-jones
Susan-bobulsky
Vendexv-pomalidomide
Obecabtagene-autoleucel

RYBREVANT®▼ (amivantamab) plus lazertinib shows longer

RYBREVANT®▼ (amivantamab) plus lazertinib shows longer
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Belgium
Hoboken
Region-flamande
Seoul
Soult-ukpyolsi
South-korea
Illinois
United-states
Chicago
Beerse
Singapore
American

Johnson & Johnson Submits Application To The European Medicines Agency Seeking Approval Of Subcutaneous Formulation Of RYBREVANT®▼ (Amivantamab) For T...

Johnson & Johnson Submits Application To The European Medicines Agency Seeking Approval Of Subcutaneous Formulation Of RYBREVANT®▼ (Amivantamab) For T...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states
Beerse
Region-flamande
Belgium
Illinois
Chicago
Canada
Singapore
Toronto
Ontario
American
Natasha-leighl